The San Francisco-based telehealth and direct-to-consumer subscription-based pharmacy service provider Him & Hers (Hims) has filed a motion to dismiss a Federal Trade Commission (FTC) lawsuit that alleged the company misled consumers about its products and data sharing practices. In August 2026, the FTC and the states of Utah and California filed a lawsuit (see below) in the U.S.

Read the full article at HIPAA Journal →